Sign up to save your podcasts
Or
Share A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
139 Listeners
NEJM This Week
321 Listeners
Practical Neurology Podcast
49 Listeners
JAMA Clinical Reviews
502 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,110 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
517 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
360 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
367 Listeners
Continuum Audio
79 Listeners